Market Overview:
The global in vitro and in vivo microelectrode array market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for advanced drug discovery and development tools, rising prevalence of neurological disorders, and growing investments by pharmaceutical and biotechnology companies in R&D activities. Based on type, the global in vitro and in vivo microelectrode array market is segmented into multiwell microelectrode arrays (MWEAs) and single well microelectrode arrays (SWMEAs). MWEAs are expected to account for a larger share of the market than SWMEAs during the forecast period. This can be attributed to their ability to simultaneously measure multiple parameters from a single sample as compared with SWMEAs. Based on application, the global in vitro and in vivo microelectrode array market is segmented into pharmaceuticals & biotechnology companies, academics & research institutions, contract research organizations (CROs), medical device manufacturers, hospitals & clinics, other end users. Pharmaceuticals & biotechnology companies are expected to account for a larger share of the market than other end users during the forecast period.
Product Definition:
Microelectrode arrays (MEAs) are devices that allow for the simultaneous measurement of the electrical activity of many cells. MEAs typically consist of a number of electrodes arranged in a grid pattern, which can be used to record the electrical activity of individual cells or groups of cells. MEAs can be used in both in vitro and in vivo settings.
Multiwell Microelectrode Array:
Multiwell microelectrode array is a new technology that has been developed to overcome the limitations of conventional single well microelectrode arrays. Conventional techniques are limited to measure blood analytes in only one type of cell, for instance, with the help of optical fibers; it is possible to determine glucose level in only one type of cell and not all types simultaneously.
Single Well Microelectrode Array:
Single well microelectrode array is a new technology that has been developed to overcome the limitations of conventional microelectrode arrays. Conventional devices have many small wells, which can be used to measure electrical activities from different regions of the cell. However, this technique suffers from drawbacks such as poor spatial resolution and inability to resolve certain events such as membrane depolarization or action potentials due to interference from other wells in the device.
Application Insights:
The others application segment includes the medical sector and research. In the medical sector, these devices are used for various purposes including drug discovery and development, toxicology testing, disease diagnosis (through clinical trials), pre-clinical studies, and in-vitro diagnostics. The pharmaceutical industry is one of the largest users of IMA as they offer a cost-effective alternative to traditional methods such as animal testing.
In addition to this purposeful use of IMA in vitro diagnostic solutions has also emerged from accidental discoveries during scientific research or when trying to find an alternative solution for a particular problem that involves bioelectrical signals transduction through cell membranes.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high research activities, and continuous development in vitro diagnostic technologies. Moreover, increasing government funding for R&D is also expected to drive this regional market over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing medical tourism industry especially from India & China regions. In addition, increasing investments by governments as well as private firms are likely to boost revenue generation in this region over next eight years.
Growth Factors:
- Increasing demand for in vitro and in vivo microelectrode arrays for drug discovery and development
- Rising prevalence of neurological disorders
- Growing number of research institutes and universities investing in microelectrode array technology
- Technological advancements in microelectrode array fabrication techniques
- Increasing focus on personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro and In Vivo Microelectrode Array Market Research Report
By Type
Multiwell Microelectrode Array, Single Well Microelectrode Array
By Application
Pharmaceutical and Biotechnology Companies, Academics and Research, Others
By Companies
Tucker Davis Technologies, Screen Holdings Co. Ltd., Plexon, Inc., Neuronexus, Neuralynx, Inc., MaxWell Biosystems AG, Harvard Bioscience, Inc., Blackrock Microsystems LLC, Axion BioSystems, Inc., 3Brain AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro and In Vivo Microelectrode Array Market Report Segments:
The global In Vitro and In Vivo Microelectrode Array market is segmented on the basis of:
Types
Multiwell Microelectrode Array, Single Well Microelectrode Array
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Academics and Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Tucker Davis Technologies
- Screen Holdings Co. Ltd.
- Plexon, Inc.
- Neuronexus
- Neuralynx, Inc.
- MaxWell Biosystems AG
- Harvard Bioscience, Inc.
- Blackrock Microsystems LLC
- Axion BioSystems, Inc.
- 3Brain AG
Highlights of The In Vitro and In Vivo Microelectrode Array Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Multiwell Microelectrode Array
- Single Well Microelectrode Array
- By Application:
- Pharmaceutical and Biotechnology Companies
- Academics and Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro and In Vivo Microelectrode Array Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro microelectrode array (IMEA) is a technology that uses microelectrodes to measure electrical activity in cells and tissues. In vivo microelectrode array (IVMA) is a technology that uses microelectrodes to measure electrical activity in living animals.
Some of the major players in the in vitro and in vivo microelectrode array market are Tucker Davis Technologies, Screen Holdings Co. Ltd., Plexon, Inc., Neuronexus, Neuralynx, Inc., MaxWell Biosystems AG, Harvard Bioscience, Inc., Blackrock Microsystems LLC, Axion BioSystems, Inc., 3Brain AG.
The in vitro and in vivo microelectrode array market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro and In Vivo Microelectrode Array Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vitro and In Vivo Microelectrode Array Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vitro and In Vivo Microelectrode Array Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vitro and In Vivo Microelectrode Array Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vitro and In Vivo Microelectrode Array Market Size & Forecast, 2018-2028
4.5.1 In Vitro and In Vivo Microelectrode Array Market Size and Y-o-Y Growth
4.5.2 In Vitro and In Vivo Microelectrode Array Market Absolute $ Opportunity
Chapter 5 Global In Vitro and In Vivo Microelectrode Array Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
5.2.1 Multiwell Microelectrode Array
5.2.2 Single Well Microelectrode Array
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vitro and In Vivo Microelectrode Array Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Academics and Research
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro and In Vivo Microelectrode Array Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro and In Vivo Microelectrode Array Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vitro and In Vivo Microelectrode Array Analysis and Forecast
9.1 Introduction
9.2 North America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
9.6.1 Multiwell Microelectrode Array
9.6.2 Single Well Microelectrode Array
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
9.10.1 Pharmaceutical and Biotechnology Companies
9.10.2 Academics and Research
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vitro and In Vivo Microelectrode Array Analysis and Forecast
10.1 Introduction
10.2 Europe In Vitro and In Vivo Microelectrode Array Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
10.6.1 Multiwell Microelectrode Array
10.6.2 Single Well Microelectrode Array
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
10.10.1 Pharmaceutical and Biotechnology Companies
10.10.2 Academics and Research
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vitro and In Vivo Microelectrode Array Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vitro and In Vivo Microelectrode Array Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
11.6.1 Multiwell Microelectrode Array
11.6.2 Single Well Microelectrode Array
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
11.10.1 Pharmaceutical and Biotechnology Companies
11.10.2 Academics and Research
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vitro and In Vivo Microelectrode Array Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
12.6.1 Multiwell Microelectrode Array
12.6.2 Single Well Microelectrode Array
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
12.10.1 Pharmaceutical and Biotechnology Companies
12.10.2 Academics and Research
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vitro and In Vivo Microelectrode Array Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vitro and In Vivo Microelectrode Array Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vitro and In Vivo Microelectrode Array Market Size Forecast by Type
13.6.1 Multiwell Microelectrode Array
13.6.2 Single Well Microelectrode Array
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vitro and In Vivo Microelectrode Array Market Size Forecast by Applications
13.10.1 Pharmaceutical and Biotechnology Companies
13.10.2 Academics and Research
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro and In Vivo Microelectrode Array Market: Competitive Dashboard
14.2 Global In Vitro and In Vivo Microelectrode Array Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Tucker Davis Technologies
14.3.2 Screen Holdings Co. Ltd.
14.3.3 Plexon, Inc.
14.3.4 Neuronexus
14.3.5 Neuralynx, Inc.
14.3.6 MaxWell Biosystems AG
14.3.7 Harvard Bioscience, Inc.
14.3.8 Blackrock Microsystems LLC
14.3.9 Axion BioSystems, Inc.
14.3.10 3Brain AG
